Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis-Reference-Cited by-同舟云学术

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis

Published:2018-09-12 Issue:10 Volume:141 Page:2834-2847
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Baker David¹,Pryce Gareth¹,Amor Sandra¹²,Giovannoni Gavin¹³,Schmierer Klaus¹³

Affiliation:

1. BartsMS, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

2. Pathology Department, Free University Amsterdam, 1081 HV Amsterdam, The Netherlands

3. Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/141/10/2834/25839164/awy239.pdf

Reference191 articles.

1. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis—targeting T or B cells?;Agahozo;Mult Scler Relat Disord,2016

2. Safety and tolerability of inebilizumab (MEDI–551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study;Agius;Mult Scler,2017

3. HLA alleles modulate EBV viral load in multiple sclerosis;Agostini;J Transl Med,2018

4. Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses;Anderson;Rheumatology,2012

5. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy;Anolik;Arthritis Rheum,2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenesis of multiple sclerosis: a series of unfortunate events;Clinical and Experimental Immunology;2023-07-06

2. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers;NeuroMolecular Medicine;2023-04-05

3. Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients;Brain Sciences;2022-11-22

4. EBV and multiple sclerosis: Setting the research agenda;Multiple Sclerosis and Related Disorders;2022-11

5. Smouldering multiple sclerosis: the ‘real MS’;Therapeutic Advances in Neurological Disorders;2022-01